Opendata, web and dolomites

TRILLIO SIGNED

TRILLIO, a porTable pRescription assistant Improving heaLth of Europeans citizens by increasing therapeutic adherence in eLderly people and in patIents affected by chrOnic diseases

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 TRILLIO project word cloud

Explore the words cloud of the TRILLIO project. It provides you a very rough idea of what is the project "TRILLIO" about.

alarm    trillio    optimizes    italian    italy    hospitals    suffering    health    automatically    visual    pilot    feasibility    chronic    sound    connections    treatment    market    abroad    time    poor    aifa    causes    turn    team    founders    difficulties    medical    carlo    minutes    sends    la    deaths    generate    startup    completing    source    plan    200    treatments    500    therapy    small    lifestyle    elderly    endorsement    selling    former    share    demo    purpose    andrea    2023    provider    players    patient    agreed    care    person    act    burdens    medication    alerts    app    billion    turnover    50    tested    innovative    nokia    112    press    notification       clock    brianza    executives    connected    suitable    diet    paper    family    right    familiar    000    display    expenditure    diseases    site    ten    really    150    button    comanda    recommendations    drug    follows    pharmaceutical    launching    distributing    adherence    mobile    executing    device    showing    off    therapeutic    population    17m    gaggi    received    sure    serval    corresponds   

Project "TRILLIO" data sheet

The following table provides information about the project.

Coordinator
LA COMANDA SRL 

Organization address
address: VIA BARTOLOMEO EUSTACHI 52
city: MILANO
postcode: 20129
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Project website http://www.trillio.org/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-05-01   to  2018-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    LA COMANDA SRL IT (MILANO) coordinator 50˙000.00

Map

 Project objective

'Therapeutic adherence is defined as “the extent to which a person’s behaviour – taking medication, following a diet, and/or executing lifestyle changes, corresponds with agreed recommendations from a health care provider”. It is estimated that each year the poor adherence to medical treatments in Europe causes about 200,000 deaths and burdens on health expenditure up to 80 billion euro a year (AIFA source). TRILLIO is a therapeutic adherence device really similar to an “alarm clock”, thus really familiar for elderly. The TRILLIO device is provided with an app that optimizes the connections among various players and organizations who share a common goal: make sure a patient follows his or her pharmaceutical treatment plan. When it's time to take a drug, TRILLIO alerts the user with a sound and a visual alarm, while showing all the relevant information on its 2.7' e-paper display. If the user doesn't press the button on the device to turn off the alarm within ten minutes, TRILLIO automatically sends a notification to any family member connected to the system. TRILLIO has been already tested in Italy and received serval endorsement by organisations in Italy and abroad. We are a targeting and overall population composed by 150.000.000 European that are suffering from Chronic diseases, 50% of them have difficulties in following a therapy: we are addressing 0,2% of this market and we are aiming at selling 112.000 devices by 2023, that will generate 17M€ turnover. The Feasibility study will have the purpose to support us in completing the market analysis, in launching a small pilot (i.e. 500/1.000 users), in identifying suitable partners in Europe for wide demo site (i.e. hospitals) and in identifying the right partners for distributing TRILLIO in Europe. TRILLIO is brought on the market by LA COMANDA, an Italian startup established under the Italian act for innovative startup, whose founders are Carlo Brianza and Andrea Gaggi, former executives of Nokia mobile team. '

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "TRILLIO" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "TRILLIO" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Colourganisms (2020)

Microbial production of custom-made, pure and sustainable anthocyanins

Read More  

TAPPXSSAI (2019)

Development of a system for automatic ad insertion into on-demand streaming video to provide new monetization mechanisms to the media industry

Read More  

BeatsDigTherapeutics (2019)

Project SCALE: Tailored Digital Therapeutics for Neurological and Brain Disorders

Read More